EVMN · Evommune, Inc.
$13.57
-1.44 (-9.59%)
At close · Aug 20
Market Cap
$531.68M
Shares
36.29M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$13.57
Open$14.76
Day$13.20–14.76
Available close range$11.05–31.57
Avg vol 30d539K
Short int4.5M · 12.3% float · 8.7d
Short vol39%
Last earningsMar 5, 2026
DataNov 2025–Aug 2026
Filing10-Q · Aug 6
The closing range uses available history since Nov 6, 2025; less than a full year is stored.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−10%
below
RSI (14)
48
neutral
MACD trend
Positive
52-week position
12%
near low
Momentum
relative strength
1-month return
+20%
trailing
6-month return
−48%
trailing
YTD return
−21%
this year
Relative strength
−59%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+26% holders QoQ · +43 funds added
Insider flow
Accumulating
Net +$146.3K over 90 days · 0% sells
Short interest
Rising
12.35% of float · ▲ +11.5% MoM · 8.7 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
106 holders — 13F breadth
Squeeze score
69
elevated · 0–100
Fundamentals
Revenue growth
+86%
Y/Y
EPS growth
+75%
Y/Y
Free cash flow
$-76.7M
Balance sheet
$44.1M
net cash
Quant / Vol
risk profile
Volatility
126%
annualized · 1-yr
Max drawdown
−65%
past year
ATR
7.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−10%
Bearish
RSI (14)
48
Neutral
MACD trend
Positive
Bullish
52-week position
12%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+26% holders QoQ · +43 funds added
Insider flow
Accumulating
Net +$146.3K over 90 days · 0% sells
Short interest
Rising
12.35% of float · ▲ +11.5% MoM · 8.7 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
106 holders — 13F breadth
Price context
position in its available closing range
Range low $11
Now $14 · 12%
Range high $32
vs 50-day avg -10%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EVMN
this stock
Evommune, Inc.
|
$531.68M | -20.7% | +85.7% | — | 12.3% |
|
ONC
BeOne Medicines Ltd.
|
$557.05B | +21.5% | +22179.2% | 856.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$136.93B | +19.2% | +46.2% | 31.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$86.39B | +7.1% | +20.8% | 20.8 | 3.3% |
|
MRNA
Moderna, Inc.
|
$69.62B | +352.1% | +4.3% | — | 12.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EVMN | -3.6% | +19.9% | -47.8% | +20.6% | -20.7% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | -1.6% | +16.6% | -59.0% | +18.5% | -32.6% |
Key facts
CIK
2044725
CUSIP
30054Y107
13F (30d)
106 filings
104 filers
Visit website
Investor relations